ExLibris header image
SFX Logo
Title: Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain.
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Young, D yr:1988


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Metzger, R. "Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues." FEBS letters 357.1 (1995): 27-32. Link to SFX for this item
2. BUNNEMANN, B. "Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization." Neuroscience Letters 114.2 (1990): 147-153. Link to Full Text for this item Link to SFX for this item
3. Kumar, M. "Selective expression of c-mas proto-oncogene in rat cerebral endothelial cells." NeuroReport 8.1 (1996): 93-6. Link to SFX for this item
4. Chisi, J E. "Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation." British journal of haematology 109.3 (2000): 563-570. Link to Full Text for this item Link to SFX for this item
5. Villar, Angela J. "Parental imprinting of the Mas protooncogene in mouse." Nature Genetics 8.4 (1994): 373-379. Link to Full Text for this item Link to SFX for this item
6. Dilauro, M. "Angiotensin-(1-7) and Its Effects in the Kidney." TheScientificWorldjournal 9 (2009): 522-535. Link to Full Text for this item Link to SFX for this item
7. Santos, Michael A. "Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas." Proceedings of the National Academy of Sciences of the United States of America 100.14 (2003): 8258-63. Link to Full Text for this item Link to SFX for this item
8. "Angiotensin-(1–7) in kidney disease: a review of the controversies." Clinical science. 123.6: 333-346. Link to SFX for this item
9. Riesewijk, Anne M. "TheMASProto-Oncogene Is Not Imprinted in Humans." Genomics 35.2 (1996): 380-382. Link to Full Text for this item Link to SFX for this item
10. Charrier, S. "Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells." Blood 104.4 (2004): 978-85. Link to SFX for this item
11. Kambayashi, Y. "Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition." The Journal of biological chemistry 268.33 (1993): 24543-6. Link to SFX for this item
12. Widdop, Robert E E. "Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats." Hypertension 45.5 (2005): 960-6. Link to SFX for this item
13. Rice, Gillian I I. "Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism." The Biochemical journal 383.1 (2004): 45-51. Link to Full Text for this item Link to SFX for this item
14. Tallant, E. "Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor." American journal of physiology. Heart and circulatory physiology 289.4 (2005): 1560-6. Link to SFX for this item
15. Brassard, P. "Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries." Hypertension 46.3 (2005): 598-606. Link to SFX for this item
16. Artuc, M. "Differential expression of angiotensin receptors in human cutaneous wound healing." British journal of dermatology 153.5 (2005): 887-93. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced